Your browser doesn't support javascript.
loading
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Alexander, Peter G; Roseweir, Antonia K; Pennel, Kathryn A F; van Wyk, Hester C; Powell, Arfon G M T; McMillan, Donald C; Horgan, Paul G; Kelly, Caroline; Hay, Jennifer; Sansom, Owen; Harkin, Andrea; Roxburgh, Campbell S D; Graham, Janet; Church, David N; Tomlinson, Ian; Saunders, Mark; Iveson, Tim J; Edwards, Joanne; Park, James H.
Afiliação
  • Alexander PG; School of Medicine, University of Glasgow, Glasgow, UK. p.alexander.1@research.gla.ac.uk.
  • Roseweir AK; School of Medicine, University of Glasgow, Glasgow, UK. antonia.roseweir@glasgow.ac.uk.
  • Pennel KAF; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. antonia.roseweir@glasgow.ac.uk.
  • van Wyk HC; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Powell AGMT; School of Medicine, University of Glasgow, Glasgow, UK.
  • McMillan DC; Division of Cancer and Genetics, Cardiff University, Cardiff, UK.
  • Horgan PG; School of Medicine, University of Glasgow, Glasgow, UK.
  • Kelly C; School of Medicine, University of Glasgow, Glasgow, UK.
  • Hay J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, UK.
  • Sansom O; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.
  • Harkin A; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Roxburgh CSD; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, UK.
  • Graham J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, UK.
  • Church DN; School of Medicine, University of Glasgow, Glasgow, UK.
  • Tomlinson I; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Saunders M; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, UK.
  • Iveson TJ; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Edwards J; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Park JH; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.
Br J Cancer ; 124(4): 786-796, 2021 02.
Article em En | MEDLINE | ID: mdl-33223535
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido